Tramadol Hydrochloride
Product Images NDC 53217-960

4 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 53217-960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 The Structural Formula Of Tramadol Hydrochloride (Tramadol HCl Er 1)

Figure 1 The Structural Formula Of Tramadol Hydrochloride (Tramadol HCl Er 1)
Chemical structure of Tramadol Hydrochloride, showing its molecular arrangement with chemical groups and bonds, including a methoxy group and hydrochloride (HCl) salt.*
FDA Label Image

Figure 2 Tamadol Er Tablets Study 023 Womac Pain Responder Analysis Patients Achieving Various Levels Of Response Threshold (Tramadol HCl Er 2)

Figure 2 Tamadol Er Tablets Study 023 Womac Pain Responder Analysis Patients Achieving Various Levels Of Response Threshold (Tramadol HCl Er 2)
A line graph depicting the percent of patients achieving response versus the response threshold in percent improvement from baseline. The graph compares the effects of Tramadol ER at 100 mg, 200 mg, 300 mg, 400 mg doses and placebo, showing decreasing patient response as the response threshold increases.*
FDA Label Image

Figure 3 Tamadol Er Tablets Study 015 Arthritis Pain Intensity Vas Responder Analysis Patients Achieving Various Levels Of Response Threshold (Tramadol HCl Er 3)

Figure 3 Tamadol Er Tablets Study 015 Arthritis Pain Intensity Vas Responder Analysis Patients Achieving Various Levels Of Response Threshold (Tramadol HCl Er 3)
A line graph comparing the percent of patients achieving a response between Tramadol ER and placebo across varying response thresholds of percent improvement from baseline. The x-axis represents the response threshold in percent, and the y-axis shows the percent of patients achieving response, with Tramadol ER consistently higher than placebo.*
FDA Label Image

Image Description (Tramadol HCl Er 4)

Image Description (Tramadol HCl Er 4)
Tramadol Hydrochloride Extended-Release capsules, 150 mg strength, packaged with 60 capsules. The label states the product is generic for CONZIP and includes details on active ingredient, appearance (white with yellow bands, oblong capsule), and packaging by Aidarex Pharmaceuticals LLC. The label also shows Rx number, NDC codes, and instructions for dosing intervals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.